Former BBC HQ the WestWorks building at White City Place is welcoming Synthace to its West London hub.
Joining tenants Mitsui Fudosan and AIMCo the company is behind the leading cloud software platform for automating and improving the success rate of biological research and development.
The announcement follows the news that NASDAQ listed biopharmaceutical company Autolus has chosen to relocate to White City Place, consolidating the site’s reputation as a new hub for rapidly scaling life science companies.
Moving from their current location in St Pancras, Synthace will take 13,000 square feet on the fourth floor of the WestWorks building.
Synthace will initially move 40 people to the site, rising to 80 within a year as the company’s growth accelerates.
“These excellent new facilities, and Stanhope and Mitsui Fudosan’s commitment to the life sciences, makes White City an ideal place to relocate and scale our business,” said Synthace chief executive Tim Fell.
“The advantages of being within a vibrant life science and tech hub are of huge benefit to a dynamic company like ours.”
A leader in computer-aided biology, Synthace’s cloud software enables life science companies to realise their Lab of the Future ambitions, where automation and AI come together to drive improvements in the speed, cost and reliability of developing biotech.
In 2016 Synthace was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum and in 2018 was selected as a Gartner ‘Cool Vendor in Life-Sciences’.
Following a £7.3m Series-A round in September 2017, the company has doubled in size and appointed Silicon Valley Veteran Bob Wiederhold as its chairman.
In addition to life-sciences, the White City Place development is already home to leading companies including the fashion technology platform Yoox Net-a-Porter, OneWeb, a satellite telecoms firm backed by Richard Branson and JellyCat, the soft-toys maker.
ITV studios also relocated their daytime production business and shows including This Morning and Loose Women from their South Bank Studios to Television centre
David Camp, chief executive of Stanhope said: “The arrival of Synthace at WestWorks, alongside neighbouring life sciences company Autolus, puts White City Place on the map as part of a leading concentration of biotechnology and biopharmaceutical companies, facilitating the growth, development and investment necessary for the ongoing success of the UK’s ‘knowledge’ economy.
“We look forward to welcoming Synthace to White City.”
Knight Frank and Cushman & Wakefield acted for Stanhope. Colliers International Life Sciences represented Synthace.